Literature DB >> 1882992

Psychosis and physical aggression in probable Alzheimer's disease.

L H Deutsch1, F W Bylsma, B W Rovner, C Steele, M F Folstein.   

Abstract

OBJECTIVE: The purpose of this study was to determine the frequency and type of psychotic symptoms in patients with probable Alzheimer's disease and to test whether there is a relationship between specific psychotic symptoms and episodes of physical aggression.
METHOD: From 209 patients with possible or probable Alzheimer's disease who had been assessed in a research clinic every 6 months for up to 4.5 years, 181 subjects with probable Alzheimer's disease were selected for study. On the basis of the summary note for each visit in the patients' charts, the presence of delusions, hallucinations, misidentifications, and episodes of physical aggression was determined. Data regarding psychotic symptoms and aggression were available for 170 and 169 subjects, respectively.
RESULTS: Delusions had been reported for 74 (43.5%) of the patients and were the most frequent psychotic symptom; persecutory delusions were the most common type. Physical aggression had been noted for 50 (29.6%) of the patients. Delusions and misidentifications frequently preceded and were significantly associated with episodes of physical aggression. The presence of delusions was a significant predictor of physical aggression but accounted for only 3.5% of the variance.
CONCLUSIONS: This study suggests that delusions are a risk factor for physical aggression in patients with probable Alzheimer's disease who have moderate to severe cognitive impairment. As delusions accounted for only a small percentage of the variance, further research is needed to identify other variables that may be significant predictors of physical aggression in this population.

Entities:  

Mesh:

Year:  1991        PMID: 1882992     DOI: 10.1176/ajp.148.9.1159

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  25 in total

Review 1.  Neuropsychiatric aspects of Alzheimer's disease.

Authors:  C Ballard; M Walker
Journal:  Curr Psychiatry Rep       Date:  1999-10       Impact factor: 5.285

Review 2.  Ethnicity and dementia.

Authors:  D G Harwood; R L Ownby
Journal:  Curr Psychiatry Rep       Date:  2000-02       Impact factor: 5.285

3.  Clinical characteristics of community-dwelling black Alzheimer's disease patients.

Authors:  D G Harwood; W W Barker; R L Ownby; R Duara
Journal:  J Natl Med Assoc       Date:  2000-09       Impact factor: 1.798

Review 4.  Alzheimer's disease and mild cognitive impairment.

Authors:  Brendan J Kelley; Ronald C Petersen
Journal:  Neurol Clin       Date:  2007-08       Impact factor: 3.806

Review 5.  North of England evidence based guidelines development project: guideline for the primary care management of dementia.

Authors:  M Eccles; J Clarke; M Livingstone; N Freemantle; J Mason
Journal:  BMJ       Date:  1998-09-19

Review 6.  Neuropathological and neuroradiological correlates of paranoid symptoms in organic mental disease.

Authors:  A Burns; H Forstl
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1997       Impact factor: 5.270

7.  ["The living image sign" in a patient with Alzheimer's disease].

Authors:  P Demers; H Létourneau; A Robillard; E St-André
Journal:  J Psychiatry Neurosci       Date:  1996-05       Impact factor: 6.186

8.  Delirium and mental health history as predictors of aggression in individuals with dementia in inpatient settings.

Authors:  Tracy Wharton; Daniel Paulson; Lisa Macri; Leslie Dubin
Journal:  Aging Ment Health       Date:  2016-09-27       Impact factor: 3.658

9.  TAR DNA-binding protein 43 pathology in Alzheimer's disease with psychosis.

Authors:  Anil Varma V Vatsavayi; Julia Kofler; Mary Ann A Demichele-Sweet; Patrick S Murray; Oscar L Lopez; Robert A Sweet
Journal:  Int Psychogeriatr       Date:  2014-03-04       Impact factor: 3.878

10.  Current electroconvulsive therapy practice and research in the geriatric population.

Authors:  Nancy Kerner; Joan Prudic
Journal:  Neuropsychiatry (London)       Date:  2014-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.